ALISPORIVIR – A HOST-TARGETING ANTIVIRAL, PROVIDES LOW VIRAL BREAKTHROUGH RATE AND HIGH BARRIER TO RESISTANCE IN HCV GENOTYPE 1 TREATMENT-NAiVE PATIENTS IN THE PHASE IIB ESSENTIAL STUDY.
- Autores: Avila C, Bao WB, Crabbe R, Jones CT, Li B, Lin K, Naoumov NV, Snoeck J, Tang J, Tiongyip C, Vandamme AM, Vuagniaux G, Yu J
- Ano de Publicação: 2011
- Journal: Hepatology
- Link: https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=46&SID=2CbhBUDoSw8ZkFBEQLW&page=1&doc=1
